Tokyo, Sept. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062989) titled 'A comparative trial of vitamin D supplementation and exercise on health outcomes in middle-aged and older women' on Sept. 19.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Japan Nutrition University
Condition:
Condition - Risk of vitamin D insufficiency or deficiency, bone and calcium metabolism, and health status related to frailty and locomotive syndrome prevention
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the effects of vitamin D supplementation at 50ug/day (2,000 IU/day), alone or in combination with exercise, on serum 25-hydroxyvitamin D [25(OH)D], serum calcium, whole parathyroid hormone (PTH), and bone turnover markers among community-dwelling middle-aged and older women during the autumn-winter season. Secondary objectives are to explore the effects on muscle strength, physical function, bone density, neuromuscular function, self-reported health status, sleep, skin condition, common cold symptoms, and pain-related outcomes.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Group A, vitamin D supplementation alone: No exercise instruction. Participants will take an active study tablet containing vitamin D 50 ug/day (2,000 IU/day) for 3 months.
Interventions/Control_2 - Group B, exercise alone: Participants will attend a supervised exercise class once weekly for 75 minutes, 12 sessions in total, and take a placebo tablet for 3 months. The exercise program consists of stretching, resistance exercise, aerobic exercise, and coordination exercise with progressive intensity increased every 2 weeks under the supervision of physical therapists.
Eligibility:
Age-lower limit - 40
years-old
=
Gender - Female
Key inclusion criteria - 1. Women aged 40 to 79 years as of March 31, 2027
2. Not receiving strict dietary guidance from a physician or other health professional
3. Not engaging in regular moderate or higher intensity exercise at least twice per week
4. Not regularly taking supplements for osteoporosis prevention containing vitamin D
5. Not currently receiving treatment for osteoporosis, diabetes mellitus, chronic kidney disease, thyroid disease, or related conditions
6. Able to provide written informed consent
Key exclusion criteria - 1. Individuals judged unable to continue the 3-month intervention program
2. Individuals with safety concerns regarding intake of the study food, participation in exercise classes, blood or urine sampling, or physical function measurements
3. Individuals judged by the principal investigator or co-investigators to be inappropriate for participation
Target Size - 120
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 15 Day
Date of IRB - 2026 Year 08 Month 05 Day
Anticipated trial start date - 2026 Year 09 Month 19 Day
Last follow-up date - 2026 Year 12 Month 19 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072003
Disclaimer: Curated by HT Syndication.